Send the following on WhatsApp
Continue to ChatA Phase I/IIa Clinical Trial of an Autologous Tumor/Dendritic Cell Fusion (Dendritoma) Vaccine with Low Dose Interleukin-2 in Stage IV Melanoma https://www.sages.org/meetings/annual-meeting/abstracts-archive/a-phase-iiia-clinical-trial-of-an-autologous-tumordendritic-cell-fusion-dendritoma-vaccine-with-low-dose-interleukin-2-in-stage-iv-melanoma/